Synthesis of 1-β-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (β-IAZA): A novel marker of tissue hypoxia

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 4, 2003, Pages 399-403

  Kumar, Piyush ^a   Ohkura, Kazue ^b   Beiki, Davood ^c   Wiebe, Leonard Irving ^a   Seki, Koh Ichi ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1 D (5 deoxy 5 iodoarabinofuranosyl) 2 nitroimidazole ( IAZA); Azomycin nucleoside; Hypoxia marker; Synthesis

Indexed keywords

1 BETA DEXTRO (5 DEOXY 5 IODOARABINOFURANOSYL) 2 NITROIMIDAZOLE; IODINE 123; NITROIMIDAZOLE DERIVATIVE; TRIPHENYLPHOSPHINE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; IODOAZOMYCIN ARABINOSIDE;

ARTICLE; DEPROTECTION REACTION; DIAGNOSTIC PROCEDURE; HYPOXEMIA; IODINATION; PATHOLOGY; SYNTHESIS; CELL HYPOXIA; CHEMISTRY; PHYSIOLOGY; STEREOISOMERISM;

BIOLOGICAL MARKERS; CELL HYPOXIA; NITROIMIDAZOLES; STEREOISOMERISM;

EID: 0242380664     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.399     Document Type: Article

References (31)

1. Tomlinson R. H., Gray L. H., Br. J. Cancer, 9, 539-549 (1955).
2. Brown J. M., Cancer Res., 59, 5863-5870 (1999).
3. Biaglow J. E., Varnes M. E., Roizen-Towle L., Clark E. P., Epp E. R., Astor M. B., Hall E. J., Biochem. Pharmac., 35, 77-90 (1986).
4. Adams G. E., Flockhart I. R., Smithen C. E., Stratford I. J., Wardman P., Watts M. E., Radiat. Res., 67, 9-20 (1976).
5. Chapman J. D., Franko A. J., Sharplin J. A., Br. J. Cancer, 43, 546-550 (1981).
6. Jette D. C., Wiebe L. I., Flanagan R. J., Lee J., Chapman J. D., Radiat. Res., 105, 169-179 (1986).
7. Wiebe L. I., Jette D. C., Chapman J. D., Flanagan R. J., Meeker B. E., "Nuclear Medicine in Clinical Oncology," ed. by Winkler C., Springer-Verlag, 1986, pp. 402-407.
8. Mannan R. H., "Novel Non-Invasive Markers of Tumor Hypoxia," Ph.D. thesis, University of Alberta, Edmonton, Canada., 1991, pp. 89-90, 145-146.
9. Parliament M. B., Chapman J. D., Urtasun R. C., McEwan A. J., Golberg L., Mercer J. R., Mannan R. H., Wiebe L. I., Br. J. Radiol., 65, 90-95 (1991).
10. Groshar D., McEwan A. J. B., Parliament M. B., Urtasun R. C., Golberg L. E., Hoskinson M., Mercer J. R., Mannan R. H., Wiebe L. I., Chapman J. D., J. Nucl. Med., 34, 885-888 (1993).
11. Urtasun R. C., Parliament M. B., McEwan A. J., Mercer J. R., Mannan R. H., Wiebe L. I., Morin C., Chapman J. D., Br. J. Cancer, 74, S209-S212 (1996).
12. Al-Arafaj A., Ryan E. A., Hutchinson K., Mannan R. H., Mercer J., Wiebe L. I., McEwan A. J. B., Europ. J. Nucl. Med., 21, 1338-1442 (1994).
13. McEwan A. J. B., Skeith K. J., Mannan R. H., Davies N., Jamali F., Schmidt R., Golberg K., Wiebe L. I., J. Nucl. Med., 38 (Suppl.), 300-301 (1997).
14. Vinjamuri S., O'Driscol K., Maltby P., McEwan A. J., Wiebe L. I., Critchley M., Clin. Nucl. Med., 24, 891-892 (1999).
15. Mannan R. H., Somayaji V. V., Lee J., Mercer J. R., Chapman J. D., Wiebe L. I., J. Nucl. Med., 32, 1764-1770 (1991).
16. Edwards D. I., J. Antimicrob. Chemother., 31, 9-20 (1993).
17. Lee H. C., Kumar P., Wiebe L. I., Mercer J. R., Ohkura K., Seki K., Nucleosides & Nucleotides, 18, 1995-2016 (1999).
18. Wang L., Wiebe L. I., Unpublished.
19. Cass C. E., "Drug Transport in Antimicrobial and Anticancer Chemotherapy," ed. by Georgopapadakou N. H., Marcel Deker, New York, 1995, pp. 403-451.
20. Baker R. B., Joseph J. P., Schraub R. E., J. Am. Chem. Soc., 77, 5905-5910 (1955).
21. Glaudemans C. P. J., Fletcher H. G., Jr., J. Org. Chem., 28, 3004-3006 (1963).
22. Kumar P., Wiebe L. I., Atrazheva E., Tandon M., Tetrahedron Lett., 42, 2077-2078 (2001).
23. Kumar P., Wiebe L. I., Unpublished.
24. Cheriyan U. O., Ogilvie K. K., Nucleosides & Nucleotides, 1, 233-237 (1982).
25. Nakajima N., Horita K., Abe R., Yonemitsu O., Tetrahedron Lett., 29, 4139-4142 (1988).
26. Sugawara T., Ishikura T., Itoh T., Mizuno Y., Nucleosides & Nucleotides, 1, 239-251 (1982).
27. Kumar P., Wiebe L. I., Beiki D., Ohkura K., Seki K., Tetrahedron Lett., 43, 4427-4429 (2002).
28. Wiley G. A., Rein B. M., Hershkowitz R. L., Tetrahedron Lett., 1964, 2509-2513 (1964).
29. Silverstein R. M., Bassler G. C., Morrill T. C., "Spectrometric Identification of Organic Compounds," 4th Ed. Pub. John Willey & Sons, New York, 1981, pp. 181-303.
30. Optimized structure was obtained by the AM1 method with MOPAC on CAChe Work system (Release 3.7) on a personal computer and the result was traced by using "CS ChemDraw ProI).
31. Lee H.C., "Novel Radioiodinated IAZA Metabolites for SPECT," Ph. D. thesis. University of Alberta, Edmonton, Canada, 1998, pp. 170-175.